chr17-5003999-A-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_006612.6(KIF1C):āc.866A>Cā(p.Gln289Pro) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0014 in 1,613,864 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006612.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KIF1C | NM_006612.6 | c.866A>C | p.Gln289Pro | missense_variant, splice_region_variant | 11/23 | ENST00000320785.10 | |
KIF1C | XM_005256424.3 | c.866A>C | p.Gln289Pro | missense_variant, splice_region_variant | 12/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KIF1C | ENST00000320785.10 | c.866A>C | p.Gln289Pro | missense_variant, splice_region_variant | 11/23 | 1 | NM_006612.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00105 AC: 159AN: 152054Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00111 AC: 279AN: 251488Hom.: 2 AF XY: 0.00125 AC XY: 170AN XY: 135922
GnomAD4 exome AF: 0.00144 AC: 2102AN: 1461692Hom.: 4 Cov.: 31 AF XY: 0.00146 AC XY: 1060AN XY: 727162
GnomAD4 genome AF: 0.00104 AC: 159AN: 152172Hom.: 1 Cov.: 32 AF XY: 0.000874 AC XY: 65AN XY: 74392
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | KIF1C: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 27, 2020 | - - |
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Dec 12, 2016 | - - |
Spastic ataxia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at